GI Dynamics’ EndoBarrier(TM) Gastrointestinal Liner to be Highlighted at Several Prominent International Diabetes and Obesity Meetings

LEXINGTON, Mass.--(BUSINESS WIRE)--GI Dynamics, a leader in non-surgical, endoscopic approaches for the treatment of type 2 diabetes and obesity, today announced that its EndoBarrier Gastrointestinal Liner will be highlighted by leading experts in metabolic disorders and endoscopy at several international diabetes and obesity meetings.

MORE ON THIS TOPIC